Developing and Validating a Simple Risk Score for Patients with Acute Myocardial Infarction

Area of Science:

• Cardiology
• Clinical Risk Stratification
• Biostatistics

Background:

• Mortality from acute myocardial infarction (AMI) remains a significant clinical challenge.
• Effective risk stratification is crucial for managing AMI patients post-intervention.

Purpose of the Study:

• To develop and validate a novel, simple risk score for predicting 4-year all-cause mortality in patients with AMI.
• To assess the performance of the new score against existing risk stratification tools.

Main Methods:

• Utilized data from the CatLet validation trial and its extension for derivation and validation.
• Employed Lasso regression analysis for covariate selection and coefficient estimation.
• The endpoint was 4-year all-cause mortality in patients undergoing percutaneous intervention (PCI).

Main Results:

• Developed the BACEF score, incorporating serum albumin, age, serum creatinine, and LVEF.
• Achieved strong predictive performance with AUCs ranging from 0.83 to 0.89 across validation sets.
• The BACEF score demonstrated superior performance compared to ACEF, ACEF II, and GRACE scores for 4-year mortality prediction.

Conclusions:

• The novel BACEF score is a simple, validated, and well-calibrated tool for risk stratification in AMI patients.
• This score has the potential to be a valuable instrument for clinicians in managing long-term outcomes for AMI survivors.